Twist Bioscience: Die DNA-Fabrik vor dem operativen Wendepunkt
Twist Bioscience hat die DNA-Herstellung revolutioniert, indem das Unternehmen genetische Bausteine im Großmaßstab auf proprietären Siliziumchips statt in traditionellen…
137,955$
1,19%
Echtzeit-Aktienkurs Twist Bioscience Corp.
Bid:
Ask:
Nachrichten zur Twist Bioscience Corp. Aktie
Why is Twist Bioscience stock sliding today?
Why is Twist Bioscience stock sliding today?…
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock
Cathie Wood’s ARK sells Twist Bioscience, buys Circle Internet stock…
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock
Cathie Wood’s ARK buys Coinbase, sells Twist Bioscience stock…
Twist Bioscience: DNA auf Chips! Umsatzrekord und AWS-Deal könnte für Twist den Durchbruch bringen!
Nun soll es endlich zu einem finalen Deal zwischen den USA und Iran gekommen sein, der bereits Ende dieser Woche…
Cathie Wood’s ARK sells Teradyne, Iridium, and Twist Bioscience stock
Cathie Wood’s ARK sells Teradyne, Iridium, and Twist Bioscience stock…
Twist Bioscience: Wird die DNA-Revolution jetzt an der Börse neu bewertet?
Twist Bioscience ist ein US-amerikanisches Biotechnologieunternehmen, das sich auf die Herstellung synthetischer DNA spezialisiert hat. Im Zentrum steht eine eigene…
Cathie Wood trims $3.17M of surging bioscience stock
There is a pattern to how Cathie Wood exits positions. It rarely happens in one move. It happens in layers,…
Twist Bioscience Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.DATEMonday, February 2, 2026 at 8 a.m. ETCALL PARTICIPANTSChief Executive Officer and Co-Founder — Dr. Emily…
Twist Bioscience stock rises 5% on revenue beat, raised guidance By Investing.com
Twist Bioscience stock rises 5% on revenue beat, raised guidance…
Twist Bioscience shares drop 9% on wider than expected Q4 loss By Investing.com
Twist Bioscience shares drop 9% on wider than expected Q4 loss…
Twist Bioscience (TWST) Q3 Profit Surges
Key PointsEarnings per share (GAAP) came in at $0.33, beating analyst estimates by $0.87 (GAAP) and marking a dramatic turnaround…
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do…
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of -17.86% and 0.95%, respectively, for the quarter ended March 2025. Do…
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest…
Twist Bioscience (TWST) Upgraded to Buy: Heres What You Should Know
Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
Scotiabank lifts Twist Bioscience target to $62, keeps top rating By Investing.com
Scotiabank lifts Twist Bioscience target to $62, keeps top rating…
Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of 14.52% and 2.04%, respectively, for the quarter ended December 2024. Do…
Here Are the 6 Largest Stock Holdings in All of Cathie Woods ETFs Right Now
Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs.…
Twist Bioscience exec sells $14,189 in stock By Investing.com
Twist Bioscience exec sells $14,189 in stock…
Twist Bioscience Aktie: Kooperationen sorgen für Schub!
Die Twist Bioscience Corporation verzeichnete am 7. Dezember 2024 eine bemerkenswerte Entwicklung an der Börse. Der Aktienkurs stieg um 3,86…
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding…
Twist Bioscience: A Post-Earnings Assessment
…
Twist Bioscience: Market Jitters Could Create A Buying Opportunity
…
Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)
…
Take the Zacks Approach to Beat the Markets: NVIDIA, Twist Bioscience, Ollies Bargain Outlet in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…
Barclays maintains Overweight on Twist Bioscience shares, sees opportunity By Investing.com
Barclays maintains Overweight on Twist Bioscience shares, sees opportunity…
Twist Bioscience launches MGF product, stock climbs 10%
…
Twist Bioscience: NGS Is Taking Off
…
Earnings call: Twist Bioscience sees robust revenue growth in Q2 By Investing.com
Earnings call: Twist Bioscience sees robust revenue growth in Q2…
Cathie Wood’s ARK ETFs buy Roku, Twist Bioscience stock By Investing.com
Cathie Wood’s ARK ETFs buy Roku, Twist Bioscience stock…
Twist Bioscience CEO sells over $37k in company stock By Investing.com
Twist Bioscience CEO sells over $37k in company stock…
Twist Bioscience executive sells shares worth over $7,700 By Investing.com
Twist Bioscience executive sells shares worth over $7,700…